Decentralized and adaptive trial designs move from pilot to default in biotech development plans
Dr. Dereck Mush, MD, MBA
What they do
ProofPilot offers a clinical trial automation platform that guides research sites and participants through complex protocols. Life science companies buy the software to design, deploy, and execute digital and hybrid trials while ensuring patient compliance through automated task workflows.
The record
- Vertical
- Clinical Trials
- Sub-segment
- Trial administration
- Product type
- Platform software
- Stage
- Series B
- Headquarters
- New York, United States
- Region
- North America
- Founded
- 2014
- Total funding
- $15M raised
Notable investors: Mitsui & Co, First Trust Capital Partners, Sopris Capital.
Also in Clinical Trials
Related on The Signal
Dr. Dereck Mush, MD, MBA
Oracle and AstraZeneca: Bringing Clinical Trials Closer to Care
Dr. Dereck Mush, MD, MBA
Decentralized Clinical Trials Promised Faster Recruitment. The Evidence on Actual Performance Is In.
Dr. Dereck Mush, MD, MBA
Unlocking Orphan Neuromuscular Indications: Why IntraBio's Aqneursa Approval Signals a Regulatory Re-evaluation of Small-Cohort Crossover Trials
Dr. Dereck Mush, MD, MBA